|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/86 | (2006.01) |
| C07K 14/47 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 4017871 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20765424.5 |
| Date of filing the European patent application | 2020-08-21 | |
| (97) | Date of publication of the European application | 2022-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-17 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/US2020/047339 |
| Date | 2020-08-21 |
| (87) | Number | WO 2021/035120 |
| Date | 2021-02-25 |
| (30) | Number | Date | Country code |
| 201962889749 P | 2019-08-21 | US | |
| 202063014934 P | 2020-04-24 | US | |
| 202063022843 P | 2020-05-11 | US |
| (72) |
RODINO-KLAPAC, Louise , US
GRIFFIN, Danielle , US
MENDELL, Jerry, R. , US
|
| (73) |
Research Institute at Nationwide
Children's Hospital ,
700 Children's Drive, Room W172,, Columbus, Ohio 43205,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Alfa-sarkoglikano pristatymas adeno-asocijuoto viruso vektoriumi ir raumenų distrofijos gydymas |
| ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY |
| Payment date | Validity (years) | Amount | |
| 2025-08-04 | 6 | 139.00 EUR |
| 2026-08-21 |